ArticleDrug design, development and therapy2025
Ultrasound Evaluation of the Effect of Impaired Vascular Dilation Function in Diabetic Patients on the Vasodilatory Effect of Nitroglycerin During the Perioperative Period - A Prospective Trial Cohort Study.
Article in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetes mellitus (DM) is associated with vascular endothelial dysfunction, which may impair perioperative responsiveness to vasoactive drugs such as nitroglycerin. Objective: This study aimed to assess vasodilatory dysfunction in diabetic patients using high-resolution ultrasound, compare their nitroglycerin response with non-diabetics during anesthesia emergence, and evaluate how endothelial impairment affects nitroglycerin-mediated vasodilation to guide personalized dosing. Methods: This prospective cohort study compared 40 non-diabetic (Group A) and 40 diabetic patients (Group B). Preoperative brachial artery ultrasound assessed flow-mediated dilation (FMD) and nitroglycerin-induced dilation (NID). Following extubation, the total nitroglycerin dose required to restore blood pressure to baseline was recorded as the primary endpoint. Secondary endpoints comprised FMD and NID values, ED Results: Compared with Group A, the nitroglycerin dose was significantly higher in Group B (48.47±5.11 µg vs 39.74±4.15 µg; mean difference: 8.73 µg, 95% CI: 6.82-10.64; P<0.001). Group B showed significantly lower FMD (3.68±1.70% vs 8.45±1.77%; mean difference: -4.77%, 95% CI: -5.65 to -3.89; P<0.001) and NID (5.07±2.63% vs 9.15±2.99%; mean difference: -4.08%, 95% CI: -5.27 to -2.89; P<0.001). Both FMD and NID correlated negatively with nitroglycerin dose (r=-0.653 and r=-0.610, respectively; both P<0.001). Diabetic patients required higher effective doses (ED Conclusion: This prospective cohort study demonstrated that impaired vascular endothelial function in diabetic patients significantly reduced sensitivity to nitroglycerin perioperatively. This was manifested by the requirement for higher nitroglycerin doses to achieve target baseline blood pressure levels during hemodynamic management following extubation. These findings suggest that preoperative vascular ultrasound may provide an individualized nitroglycerin dosing framework for diabetic patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.